AGILERA
LIVE

Serial Number

99536140

Owner

Agilera Pharma AS

Attorney

Katherine P. Califa

Filing Date

Dec 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AGILERA Trademark

Serial Number: 99536140

AGILERA is a trademark filed by Agilera Pharma AS on December 8, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Agilera Pharma AS

Instituttveien 18

Entity Type: 98

Trademark Details

Filing Date

December 8, 2025

Registration Date

Not Registered

Goods & Services

Distributorship services in the field of radiopharmaceuticals; distributorship services featuring pharmaceuticals, radiopharmaceuticals, and nuclear medicine products; business management and logistics management in the field of radiopharmaceuticals; supply chain management for pharmaceutical and radiopharmaceutical products; business administration and consulting services for radiopharmaceutical and radiopharmacy operations; Regulatory submission management services, namely, assisting others in preparing and filing applications for radiopharmaceuticals with governmental regulatory bodies

isotope production for medical, research, and commercial use; contract development and manufacturing services (CDMO) in the field of pharmaceuticals and radiopharmaceuticals; Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials; Manufacturing services in the field of pharmaceuticals and radiopharmaceuticals; Custom manufacture of pharmaceuticals

laboratory testing, quality control, and validation services for radiopharmaceuticals; process development, optimization, and scale-up services; technological consultancy relating to radiopharmaceutical production and regulatory compliance; Pharmaceutical drug development services; Laboratory services for the production of radiopharmaceuticals in the nature of research and development of new products and testing of pharmaceuticals; Quality control for others; Scientific and technological services and research in the field of radiochemistry, radiopharmaceuticals, and nuclear medicine

Supply chain and logistics services, namely, transportation, delivery, distribution, and storage of radiopharmaceuticals and radioisotopes; consultation and coordination services relating to the transport and storage of radiopharmaceuticals and radioisotopes

Radiopharmaceutical and radioisotope preparations for clinical, medical, diagnostic and therapeutic use

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 20, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 13, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 8, 2025 MAFR
NEW APPLICATION ENTERED
Dec 8, 2025 NWAP